These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 36043134)
1. Noninvasive Prenatal Diagnosis of Fetal RHD Status Using Cell-free Fetal DNA in Maternal Plasma. Ahmadi MH; Pourfathollah AA; Rabiee M; Amirizadeh N J Reprod Infertil; 2022; 23(2):128-134. PubMed ID: 36043134 [TBL] [Abstract][Full Text] [Related]
3. Fetal RHD Genotyping Using Real-Time Polymerase Chain Reaction Analysis of Cell-Free Fetal DNA in Pregnancy of RhD Negative Women in South of Iran. Moezzi L; Keshavarz Z; Ranjbaran R; Aboualizadeh F; Behzad-Behbahani A; Abdullahi M; Ramezani A; Samsami A; Sharifzadeh S Int J Fertil Steril; 2016; 10(1):62-70. PubMed ID: 27123202 [TBL] [Abstract][Full Text] [Related]
4. A new biosensor for noninvasive determination of fetal RHD status in maternal blood of RhD negative pregnant women. Dündar Yenilmez E; Kökbaş U; Kartlaşmış K; Kayrın L; Tuli A PLoS One; 2018; 13(6):e0197855. PubMed ID: 29874251 [TBL] [Abstract][Full Text] [Related]
5. Fetal RHD Genotyping from Circulating Cell-Free Fetal DNA in Plasma of Rh Negative Pregnant Women in Iran. Ahmadi MH; Hantuoshzadeh S; Okhovat MA; Nasiri N; Azarkeivan A; Amirizadeh N Indian J Hematol Blood Transfus; 2016 Dec; 32(4):447-453. PubMed ID: 27812255 [TBL] [Abstract][Full Text] [Related]
6. Determination of fetal RHD type in plasma of RhD negative pregnant women. Sørensen K; Kjeldsen-Kragh J; Husby H; Akkök ÇA Scand J Clin Lab Invest; 2018 Sep; 78(5):411-416. PubMed ID: 29869532 [TBL] [Abstract][Full Text] [Related]
7. Reliable Determination of Fetal RhD Status by RHD Genotyping from Maternal Plasma. Dovč-Drnovšek T; Klemenc P; Toplak N; Blejec T; Bricl I; Rožman P Transfus Med Hemother; 2013 Feb; 40(1):37-43. PubMed ID: 23637648 [TBL] [Abstract][Full Text] [Related]
8. Routine noninvasive prenatal screening for fetal Rh D in maternal plasma-A 2-year experience from a single center in Belgium. Blomme S; Nollet F; Rosseel W; Bogaard N; Devos H; Emmerechts J; Cauwelier B Transfusion; 2022 May; 62(5):1103-1109. PubMed ID: 35352833 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of RhD status and clinical application of non-invasive prenatal determination of fetal RHD in maternal plasma: a 5 year experience in Cyprus. Papasavva T; Martin P; Legler TJ; Liasides M; Anastasiou G; Christofides A; Christodoulou T; Demetriou S; Kerimis P; Kontos C; Leontiades G; Papapetrou D; Patroclos T; Phylaktou M; Zottis N; Karitzie E; Pavlou E; Kountouris P; Veldhuisen B; van der Schoot E; Kleanthous M BMC Res Notes; 2016 Apr; 9():198. PubMed ID: 27036548 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of non-invasive prenatal RHD genotyping of the fetus. Hyland CA; Gardener GJ; Davies H; Ahvenainen M; Flower RL; Irwin D; Morris JM; Ward CM; Hyett JA Med J Aust; 2009 Jul; 191(1):21-5. PubMed ID: 19580531 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic accuracy of fetal rhesus D genotyping using cell-free fetal DNA during the first trimester of pregnancy. Vivanti A; Benachi A; Huchet FX; Ville Y; Cohen H; Costa JM Am J Obstet Gynecol; 2016 Nov; 215(5):606.e1-606.e5. PubMed ID: 27393271 [TBL] [Abstract][Full Text] [Related]
14. Hypermethylated RASSF1A in maternal plasma: A universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Chan KC; Ding C; Gerovassili A; Yeung SW; Chiu RW; Leung TN; Lau TK; Chim SS; Chung GT; Nicolaides KH; Lo YM Clin Chem; 2006 Dec; 52(12):2211-8. PubMed ID: 17068167 [TBL] [Abstract][Full Text] [Related]
15. Noninvasive Antenatal Screening for Fetal RHD in RhD Negative Women to Guide Targeted Anti-D Prophylaxis. Clausen FB; Rieneck K; Krog GR; Bundgaard BS; Dziegiel MH Methods Mol Biol; 2019; 1885():347-359. PubMed ID: 30506209 [TBL] [Abstract][Full Text] [Related]
16. Noninvasive fetal RHD genotyping from maternal plasma in an admixed Brazilian population. Schmidt LC; Cabral AC; Faria MA; Monken F; Tarazona-Santos E; Martins ML Genet Mol Res; 2014 Feb; 13(1):799-805. PubMed ID: 24615044 [TBL] [Abstract][Full Text] [Related]
17. Determination of fetal rhesus d status by maternal plasma DNA analysis. Aykut A; Onay H; Sagol S; Gunduz C; Ozkinay F; Cogulu O Balkan J Med Genet; 2013 Dec; 16(2):33-8. PubMed ID: 24778561 [TBL] [Abstract][Full Text] [Related]
19. Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service. Finning KM; Martin PG; Soothill PW; Avent ND Transfusion; 2002 Aug; 42(8):1079-85. PubMed ID: 12385421 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of prenatal RHD typing strategies on cell-free fetal DNA from maternal plasma. Grootkerk-Tax MG; Soussan AA; de Haas M; Maaskant-van Wijk PA; van der Schoot CE Transfusion; 2006 Dec; 46(12):2142-8. PubMed ID: 17176327 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]